The Hindu Business Line : Anti-anaemia drug launched

TARGETTING the side-effects posed by the drugs used to treat iron deficiency (anaemia), Vanguard Therapeutics Pvt Ltd (VTPL), the city-based pharmaceutical formulations company, has launched a drug using novel drug delivery system.

Addressing a news conference here on Tuesday, the VTPL Managing Director, Mr P. Koteswara Rao, said the company for the first time in the country has introduced timed-release haematinic capsules of carbonyl iron with zinc and antioxidants.

Branded `VIP-Z', the drug has the dual advantage of building blood and foetal cells with simultaneous protection from oxidative free radical stress, Mr Rao claimed. According to him, the existing products in the market were falling short in this respect.

VIP-Z, claimed to be containing the latest and best iron called carbonyl iron, given in the timed release dosage system, would be delivered into duodenum, where maximal absorption of iron takes place, bypassing the release in the stomach to avoid gastric upset, Mr Rao said. "Both zinc and antioxidants are timed to be released in the upper portion of the small intestine."

Mr Koteswara Rao expected that the new drug of the company would effectively address the most common medical problem of iron intolerance encountered by the doctors in the treatment of iron deficiency anaemia, which was generally dose related and individualistic in nature.

Article E-Mail :: Comment :: Syndication

Stories in this Section
Interim chief for Kerala SHRC

Earnings growth at 31.7 pc in Sept quarter

Campaign for birth certificate

Socio-economic survey of Srivilliputtur

Hungary's EU accession to help Indian exports

5 healthcare projects in WB

Anti-anaemia drug launched

`Plea to make core sector funding more transparent'

Kerala to hike tax on `white' kerosene

Bengal SEB to get rebate for timely payment of bills

Transco gets Centre's nod to swap high-cost loans